Statement Of Financial Position [Abstract]
| Concept |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2021-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
As at 2020-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Statement of financial position [abstract] | ||||||||||||||||||
| Assets [abstract] | ||||||||||||||||||
| Non-current assets [abstract] | ||||||||||||||||||
| Property, plant and equipment |
303,122,000
USD
|
— | — | — | — | — |
264,449,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Right-of-use assets |
2,512,000
USD
|
— | — | — | — | — |
2,604,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Trade and other non-current receivables |
1,343,000
USD
|
— | — | — | — | — |
26,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Non-current assets |
308,150,000
USD
|
— | — | — | — | — |
267,833,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current assets [abstract] | ||||||||||||||||||
| Current inventories |
4,368,000
USD
|
— | — | — | — | — |
6,590,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Trade and other current receivables |
1,847,000
USD
|
— | — | — | — | — |
1,449,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current biological assets |
18,690,000
USD
|
— | — | — | — | — |
16,795,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Cash and cash equivalents |
24,103,000
USD
|
— | — | — | — | — |
17,480,000
USD
|
— | — | — | — | — |
28,909,000
USD
|
— | — | — | — | — |
| Current assets |
49,401,000
USD
|
— | — | — | — | — |
43,907,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Assets |
357,551,000
USD
|
— | — | — | — | — |
311,740,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities [abstract] | ||||||||||||||||||
| Equity [abstract] | ||||||||||||||||||
| Issued capital |
1,716,000
USD
|
— | — | — | — | — |
1,051,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Retained earnings |
280,409,000
USD
|
— | — | — | — | — |
215,403,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Share premium |
577,805,000
USD
|
— | — | — | — | — |
454,256,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Equity |
296,382,000
USD
|
577,805,000
USD
|
4,319,000
USD
|
280,409,000
USD
|
1,716,000
USD
|
7,049,000
USD
|
239,556,000
USD
|
215,403,000
USD
|
454,256,000
USD
|
3,741,000
USD
|
4,089,000
USD
|
1,051,000
USD
|
255,459,000
USD
|
917,000
USD
|
82,625,000
USD
|
185,000
USD
|
335,337,000
USD
|
2,015,000
USD
|
| Liabilities [abstract] | ||||||||||||||||||
| Non-current liabilities [abstract] | ||||||||||||||||||
| Non-current liabilities |
30,505,000
USD
|
— | — | — | — | — |
52,842,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current liabilities [abstract] | ||||||||||||||||||
| Trade and other current payables |
11,698,000
USD
|
— | — | — | — | — |
19,018,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Current liabilities |
30,664,000
USD
|
— | — | — | — | — |
19,342,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Liabilities |
61,169,000
USD
|
— | — | — | — | — |
72,184,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Equity and liabilities |
357,551,000
USD
|
— | — | — | — | — |
311,740,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |